Ø T Førre

Summary

Publications

  1. pmc Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study
    A S Kåss
    Department of Rheumatology, Betanien Hospital, Skien, Norway
    Scand J Rheumatol 43:22-7. 2014
  2. doi request reprint The association of luteinizing hormone and follicle-stimulating hormone with cytokines and markers of disease activity in rheumatoid arthritis: a case-control study
    Anita S Kåss
    Department of Rheumatology, Betanien Hospital, Skien, Norway
    Scand J Rheumatol 39:109-17. 2010

Collaborators

  • I Hollan
  • A S Kåss
  • P A Torjesen
  • H C Gulseth
  • Anita S Kåss
  • M W Fagerland
  • O T Førre
  • T E Lea

Detail Information

Publications2

  1. pmc Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study
    A S Kåss
    Department of Rheumatology, Betanien Hospital, Skien, Norway
    Scand J Rheumatol 43:22-7. 2014
    ..The aim of this study was to assess short-term cetrorelix therapy in rheumatoid arthritis (RA) patients...
  2. doi request reprint The association of luteinizing hormone and follicle-stimulating hormone with cytokines and markers of disease activity in rheumatoid arthritis: a case-control study
    Anita S Kåss
    Department of Rheumatology, Betanien Hospital, Skien, Norway
    Scand J Rheumatol 39:109-17. 2010
    ..We wanted to investigate whether small fluctuations in these hormones could be associated with similar fluctuations in cytokines and disease activity in RA...